Subscription Required

Only paid subscribers* to Drug Benefit News can access this Web portal with three years of back issues, searchable article archives and other valuable resources.

Subscribers to Drug Benefit News receive

  • 24 biweekly issues (8 pages) of timely news and insightful strategies for reducing costs and improving outcomes, delivered First Class by U.S. Mail and electronically
  • Special E-Alerts when timely news breaks
  • Access to your subscriber-only web page with:
    • A posting of the latest issue
    • Searchable archives of all articles for the past three years
    • A chronological posting of back issues for three years
  • Recent stories of interest and hot topic articles grouped for convenient reading and regular postings from your editor
View a sample and get more information
December 19, 2014

Recent Stories of Interest

From Drug Benefit News - In a new proposed rule on benefit and payment parameters for exchange plans in 2016, HHS suggests several key changes to essential drug benefits that industry observers say more accurately reflect market-based practices. The biggest and perhaps most welcome change is a proposed reliance on pharmacy and therapeutics (P&T) committees to develop formularies, which many managed care plans already use for their other lines of business. Read more

As health plans and PBMs explore ways to rein in spending on… Read more

As payers anticipate the final wave of patent expirations and generic launches… Read more

As plan sponsors consider whether to accept the growing number of formulary… Read more

From the Editor

Welcome to your Drug Benefit News subscriber-only Web page

Be sure to visit often, for PDFs of issues, archives of articles and data, and more!

Please e-mail me with comments on the last issue of Drug Benefit News, story ideas for future issues or any other suggestions you have that can make the newsletter more useful for you.

December 18, 2014
New CVS Data Compare Harvoni, Sovaldi Use

New CVS data show Harvoni uptake rate was 2.5 times that of Sovaldi after launch.

December 16, 2014
CVS Posts 2015 Guidance

At analyst day, CVS Health posted its 2015 guidance, highlighting a successful PBM selling season.

December 10, 2014
FDA Approves Gardasil 9 Vaccine

FDA approves Merck’s Gardasil 9, a vaccine that potentially can prevent about 90% of cervical, vulvar, vaginal and anal cancers.

Updated Regularly

Featured Hot Topics

Search for your own Hot Topics

It's quick and easy to sign up for FREE access to!

Why do I need to register?